Technique can be used to better categorize patients with neurological disease, according to their therapeutic needs
Personalized medicine 鈥� delivering therapies specially tailored to a patient鈥檚 unique physiology 鈥� has been a goal of researchers and doctors for a long time. New research provides a way of delivering personalized treatments to patients with neurological disease.
Finding is key for future treatment and earlier diagnosis听
Scientists at the Montreal Neurological Institute and Hospital (The Neuro) of 海角社区 have used a unique approach to track brain degeneration in Alzheimer鈥檚 disease, uncovering a pathway through which degeneration spreads from one region to another.
Montreal 鈥� In a study published in Stem Cell Reports, a 海角社区 team of scientists led by Dr.听Carl Ernst, researcher at the Douglas Hospital Research Centre, revealed a molecular mechanism that may play a role in the development of autism.
Endowment to bolster big-data research and help establish Global Brain Consortium at Ludmer Centre
Discovery will aid diagnosis and development of treatments
Scientists at the Montreal Neurological Institute and Hospital (The Neuro) and 海角社区 have identified novel genes associated with a specific form of schizophrenia.
Schizophrenia is a major psychiatric illness affecting one per cent of the population worldwide. Patients suffering from schizophrenia present delusions, hallucinations, abnormal behavior, impairment in daily life and cognitive deficits. Current treatments are insufficient in addressing all of these symptoms.
Award-winning unit will add 10 new beds this year
听
Stroke is the third-leading cause of death in Canada. Each year, some 14,000 Canadians die as a result of a stroke.
June is Stroke Awareness Month, a time to spread awareness of the causes and effects of stroke as well as its treatment.
A look at the latest ALS research and clinical care at The Neuro
Amyotrophic lateral sclerosis (ALS) is a terrible disease with no known cure. Research at The Montreal Neurological Institute and Hospital (The Neuro) is uncovering data that could help find effective treatments for ALS.听
The Neuro鈥檚 Alain Ptito is focussing public attention on the danger of concussion
By Victor Swoboda
On the day that you read this, more than 400 Canadians on average will suffer a concussion or some other brain injury.
Djavad Mowafaghian Foundation shares The Neuro鈥檚 open science vision to accelerate drug discovery and find new and effective treatments for autism spectrum disorders
Today, May 23, 2018, The Montreal Neurological Institute and Hospital (The Neuro) gratefully acknowledged significant government funding and unveiled the Thinking Ahead Campaign (2007-2013) donor wall as a tribute and thank you to the many people who helped transform The Neuro鈥檚 ability to deliver cutting-edge research and clinical care. This ambitious campaign brought people from around the world together to share in one common goal: to accelerate the pace of neuroscience discovery and deliver exceptional care to patients.
CENTECH, a Montreal-based technology incubator, announced earlier that it has selected a company founded by Dr. Etienne de Villers-Sidani for its Propulsion Program, which helps the most innovative start-ups move from the initial development phase to commercializing their products and services on the international market. Dr. de Villers-Sidani is a researcher and neurologist at Montreal Neurological Institute and Hospital (The Neuro) and member of the Center for Research on Brain, Language and Music (CRBLM).
May is Multiple Sclerosis (MS) Month. Laboratory and clinical studies related to MS involve about 50 members of The Neuro鈥檚 staff. They study the disease in all its aspects and at every stage with the help of the most advanced brain imaging technology and the latest cell biology techniques.
While the human immunodeficiency virus (HIV) has largely dropped from news headlines since the 1990s, at the end of 2016 there were 36.7 million people living with the infection, and of those only 53 per cent had access to treatment. A new study underscores the neurological consequences of exposure to HIV without antiretroviral therapy.
On April 20, 2018, Canadian, Chinese and Cuban neuroscience institutes strengthened an existing partnership with the signing of a memorandum of understanding in Chengdu, China.
Partners in the agreement include The Montreal Neurological Institute and Hospital (The Neuro) of 海角社区, The Cuban Neuroscience Center, The University of Electronic Sciences and Technology of China, The West China Hospital, and The Tianfu New Area of Chengdu (TFNA).
April is Parkinson鈥檚 Awareness Month, a time to give special attention to a disease that affects approximately 100,000 Canadians. As a centre for both research and clinical treatment of Parkinson鈥檚 disease (PD), the Montreal Neurological Institute and Hospital (The Neuro) offers many specialized services and opportunities to participate in research to PD patients.
